Brief: Abionyx Pharma Announces Positive Preclinical Results In Model Of Uveitis

Abionyx Pharma SA

07/10/2021 06:59

Oct 7 (Reuters) - Abionyx Pharma SA  ABNX.PA :
    * ABIONYX PHARMA SA ANNOUNCES POSITIVE PRECLINICAL RESULTS
IN A
MODEL OF UVEITIS
    * LAUNCHES STRATEGIC DEVELOPMENT OF FIRST CLASS OF
BIOMEDICINES IN
OPHTHALMOLOGY BASED ON ITS BIO-HDL
    * BIO-HDL WAS FOUND TO BE COMPLETELY SAFE AND VERY WELL
TOLERATED
ON THE OCULAR SURFACE AND INSIDE THE EYE

Source text: https://bit.ly/2YoSLtw
Further company coverage:  ABNX.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))